This list is published on healthsprocket.com at Source URL: https://www.healthsprocket.com/hs/content/watson-health-perspectives-6-considerations-value-based-contracting-medications
Visit now to read comments, add your own comments and rate this list.

Fact Based List:

Watson Health Perspectives: 6 considerations for value-based contracting for medications

Submitted By Charlene Ice, Created 11/23/2020 - 16:57
  1. How life sciences companies and payers will set the correct unit of value.
  2. Clarity about who will bear the administrative burden of documenting patient outcomes.
  3. Outcomes might unintentionally drive price increases.
  4. Value-based contracts could impact off-label utilization.
  5. How this information could affect quality indicators in the future.
  6. Addressing other regulatory issues, such as Medicaid’s “best price” policy.

Source: Watson Health Perspectives/IBM, November 6, 2020
Source URL: https://www.ibm.com/blogs/watson-health/considerations-contr...
Notes: From a blog by Arti Bhavsar PharmD, Linda Elbers PharmD, and Katherine Haverty.

HealthSprocket is a service of MCOL. copyright 2010, MCOL. All rights reserved.
MCOL 1101 Standiford Ave. Suite C-3, Modesto, CA, 95350
209.577.4888 (p) | 209.77.3557(f) | info@healthsprocket.com (e)